| Financial Year |
March 31 2023 |
| Monetary Funds |
188,103,617.55 |
| Held-for-trading Financial Assets |
255,110,501.28 |
| Notes Receivable |
3,946,512.00 |
| Accounts Receivable |
258,811,265.43 |
| Advances to Suppliers |
21,228,099.78 |
| Other Receivables |
38,334,389.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,588,269.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,939,955.93 |
| Total Current Assets |
975,341,333.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
74,587,891.29 |
| Investment Properties |
-- |
| Fixed Assetes |
543,762,152.51 |
| Under-construction Projects |
758,374,934.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
133,580,043.65 |
| R&D expenses |
-- |
| Goodwill |
20,257,069.43 |
| Long-Term Deferred and Prepaid Expenses |
1,285,779.72 |
| Deferred Income Tax Assets |
13,863,572.47 |
| Other Non-Current Assets |
105,569,113.39 |
| Sub-Total of Non-Current Assets |
1,654,625,696.56 |
| Total Assets |
2,629,967,029.91 |
| Short-Term Loans |
418,012,123.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,179,800.00 |
| Accounts Payable |
132,769,240.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,200,762.45 |
| Taxes Payable |
11,124,397.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,066,425.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
13,400,529.03 |
| Sub-Total of Current Liabilities |
658,338,735.79 |
| Long-term Loans |
179,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
172,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,598,762.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
226,406,162.26 |
| Total Liabilities |
884,744,898.05 |
| Paid-In Capital(Or Share Stock) |
252,621,666.00 |
| Capital Surplus |
710,458,653.80 |
| Surplus Reserve |
47,533,813.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
667,148,370.99 |
| Minority Stockholder's Interest |
84,464,609.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,660,757,522.07 |
| Owner's Equity（Stockholder's Equity） |
1,745,222,131.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,629,967,029.91 |
